News

From November 17 to 20, MEDICA was held in Düsseldorf, Germany. This year's event attracted over 5,800 companies from more than 70 countries and regions, showcasing advanced innovations in medical technology.

Autobio presented key products at the exhibition, including the AutoLumo S900 Fully Automated Chemiluminescence Immunoassay Analyzer, the Ci-120x Fully Automated Coagulation Analyzer, and the Autof TX8 Fully Automated Microbial Mass Spectrometry Detection System.

Based on the "Lab in 0.5 ㎡" design concept, these products deliver highly efficient and precise testing capabilities within an extremely compact footprint, and provides intelligent, integrated solutions for laboratories worldwide.

At the exhibition, Autobio launched the BC120 Plus Microbial Detection System for the first time. The product drew crowds of professional visitors, with its intelligent culture workflow and efficient microbial detection capabilities garnering significant attention.

This system features a modular, expandable design, coming standard with 120 incubation positions and scalable up to 600 bottles simultaneously. In terms of performance, the system integrates 18 intelligent algorithms with PID precision temperature control technology, achieving an average positive detection time that is 2–3 hours faster than that of conventional devices. This significantly enhances the efficiency of clinical microbiological testing and provides critical support for diagnosing conditions such as sepsis.

The device's primary focus on "effortless operation" is centered on enhancing user experience. It supports QR code scanning, enabling automatic entry of sample information into the LIS system, thus eliminating the need for manual input. Its versatility is further enhanced by the inclusion of a satellite blood culture module, making it suitable for placement in emergency departments, ICUs, and satellite hospitals. Samples can be incubated on-site with simultaneous data transmission, eliminating the need for transportation. This significantly reduces the time between testing and antibiotic adjustment, supporting early diagnosis and treatment.

Autobio's booth attracted the attention from attendees. The company's international business team engaged with visitors, explaining product features and sharing Autobio's intelligence laboratory solutions.

MEDICA is a great platform for showcasing Autobio's technological results. It also paves the way for deepening international collaboration and expanding the company's global market presence. Moving forward, Autobio will continue to drive innovation, meet market needs, and commit to advance global healthcare and safeguard human health.